Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Anaphylaxis: from Bench to Bedside Issue: Current Update on Anaphylaxis

Author(s): Aslı Gelincik

Volume 29, Issue 3, 2023

Published on: 08 February, 2023

Page: [163 - 164] Pages: 2

DOI: 10.2174/138161282903230208104942

Price: $65

Next »
[1]
Muraro A, Worm M, Alviani C, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy 2022; 77(2): 357-77. PubMed
[http://dx.doi.org/10.1111/all.15032] [PMID: 34343358]
[2]
Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020; 13(10): 100472. Published 2020 Oct 30
[http://dx.doi.org/10.1016/j.waojou.2020.100472] [PMID: 33204386]
[3]
Tejedor-Alonso MA, Moro-Moro M, Múgica-García MV. Epidemiology of anaphylaxis: contributions from the last 10 years. J Investig Allergol Clin Immunol 2015; 25: 163-75. PubMed
[PMID: 26182682]
[4]
Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: Mortality rate and risk factors. J Allergy Clin Immunol Pract 2017; 5(5): 1169-78. PubMed
[PMID: 28888247]
[5]
Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA 2021; 325(11): 1101-2. PubMed
[http://dx.doi.org/10.1001/jama.2021.1967] [PMID: 33576785]
[6]
Greenhawt M, Abrams EM, Shaker M, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: A systematic review, meta-analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract 2021; 9(10): 3546-67. PubMed
[http://dx.doi.org/10.1016/j.jaip.2021.06.006] [PMID: 34153517]
[7]
Ebo D, Beyens M, Heremans K, van der Poorten ML, Van Gasse A, Mertnes C, et al. Recent knowledge and insights on the mechanisms of anaphylaxis: IgE/FcɛRI- and non-IgE/FcɛRI-dependent anaphylaxis. Curr Pharm Des 2023; 29(3): 178-84. Pub-Med
[http://dx.doi.org/10.2174/1381612829666221025091827] [PMID: 36284380]
[8]
Labella M, saenz de Santa Maria R, Bogas G, Salas M, Fernandez TD, Mayorga C, et al. Drug induced anaphylaxis. Curr Pharm Des 2023; 29(3): 196-208. Pub-Med
[http://dx.doi.org/10.2174/1381612829666221024154951] [PMID: 36284381]
[9]
Bilo BM, Danieli G, Moroncini G, Martini M. Hymenoptera venom allergy and anaphylaxis. Curr Pharm Des 2023; 29(3): 165-77. Pub-Med
[http://dx.doi.org/10.2174/1381612828666220817091039] [PMID: 35980057]
[10]
Beyaz S, Gelincik A. Anaphylaxis in risky populations. Curr Pharm Des 2023; 29(3): 224-38. Pub-Med
[http://dx.doi.org/10.2174/1381612829666221207105214] [PMID: 36503444]
[11]
Arikoglu T, Ozhan A, Kuyucu S. Management of anaphylaxis in pediatric population. Curr Pharm Des 2023; 29(3): 209-23. Pub-Med
[http://dx.doi.org/10.2174/1381612829666221021154032] [PMID: 36281867]
[12]
Alvarez-Perea A, Cabrera-Freitag P, Fuentes-Aparicio V, Infante S. Advancements in anaphylaxis management. Curr Pharm Des 2023; 29(3): 185-95. Pub-Med
[http://dx.doi.org/10.2174/1381612829666221021150946] [PMID: 36281869]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy